Kopran Limited (NSE:KOPRAN)

Market Cap	6.05B -23.5%
Revenue (ttm)	6.20B -3.7%
Net Income	165.43M -65.2%
EPS	3.42 -65.3%
Shares Out	n/a
PE Ratio	36.56
Forward PE	n/a
Dividend	3.00 (2.56%)
Ex-Dividend Date	Sep 4, 2025

Volume	224,235
Average Volume	261,654
Open	119.98
Previous Close	119.98
Day's Range	117.50 - 127.00
52-Week Range	107.00 - 214.00
Beta	0.29
RSI	48.82
Earnings Date	May 15, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1958
• Employees: 1,024
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KOPRAN

Financial Performance

In fiscal year 2025, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.